Cefotaxime – Injection products
|
Minimum Inhibitory |
Disk Diffusion |
||||
---|---|---|---|---|---|---|
Pathogen |
S |
I |
R |
S |
I |
R |
Enterobacteralesa |
M100 standard is recognized |
|||||
Acinetobacter spp. |
≤1 |
2 |
≥4 |
- |
- |
- |
Other non-Enterobacterales |
≤1 |
2 |
≥4 |
- |
- |
- |
Haemophilus influenzae and parainfluenzae |
≤1 |
- |
- |
- |
- |
- |
Neisseria gonorrhoeae |
M100 standard is recognized |
|||||
Streptococcus pneumoniae |
M100 standard is recognized |
- |
- |
- |
||
Streptococcus pneumoniae |
M100 standard is recognized |
- |
- |
- |
||
Streptococcus spp β- Hemolytic Group |
M100 standard is recognized |
|||||
Streptococcus spp Viridans Group |
M100 standard is recognized |
|||||
Neisseria meningitidis |
M100 standard is recognized |
|||||
Anaerobes |
≤1 |
2 |
≥4 |
- |
- |
- |
aIncluding Salmonella spp. and Shigella spp.
S = Susceptible; I = Intermediate; R = Resistant